Winston Kung is COO & CFO at PMV Pharmaceuticals, Inc. (PMVP). They have made 4 open-market trades across 1 company since 2021, most recently 2026-06-11.
CIK 0001666963
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CRBP | SELL · 10b5-1 | 2026-06-10 | 2026-06-11 | $7.91 | $16K | +3.6% | +14.9% | +12.4% |
| PMVP | SELL | 2021-08-03 | 2021-08-04 | $33.82 | $152K | -6.5% | -22.6% | -33.7% |
| PMVP | SELL | 2021-07-08 | 2021-07-08 | $33.75 | $152K | +10.1% | +10.0% | -11.3% |
| PMVP | SELL | 2021-06-04 | 2021-06-07 | $33.75 | $152K | +4.3% | -3.3% | -13.7% |
| PMVP | SELL | 2021-05-03 | 2021-05-04 | $33.75 | $152K | -5.9% | -1.5% | +0.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.